Carlos Costa serves as Executive at Foghorn Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Carlos Costa has executed 10 insider transactions totaling $591.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 23, 2024 involved selling 857 shares valued at $8.7K.
Carlos Costa currently holds 857 shares of Foghorn Therapeutics Inc. (FHTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carlos Costa has been a net seller of FHTX stock. They have purchased $0 and sold $591.2K worth of shares.
Carlos Costa's most recent insider trade was on Sep 23, 2024, when they sold 857 shares at $10.17 per share.
Get notified when new Form 4 filings are submitted
| $3.72 |
| Planned |
| Sep 20, 2024 | FHTX | $133.0K | Option Exercise | 35,756 | $3.72 | Planned |
| Sep 20, 2024 | FHTX | $359.0K | Sale | 35,756 | $10.04 | Planned |
| Sep 18, 2024 | FHTX | $116.3K | Sale | 11,574 | $10.05 | Planned |
| Sep 18, 2024 | FHTX | $43.1K | Option Exercise | 11,574 | $3.72 | Planned |
| Sep 17, 2024 | FHTX | $103.1K | Sale | 10,272 | $10.04 | Planned |
| Sep 17, 2024 | FHTX | $38.2K | Option Exercise | 10,272 | $3.72 | Planned |
| Sep 16, 2024 | FHTX | $4.0K | Sale | 400 | $10.00 | Planned |
| Sep 16, 2024 | FHTX | $1.5K | Option Exercise | 400 | $3.72 | Planned |